"Patients with stage III or IV kidney cancer are at high risk of recurrence ... which has many more mutations and therefore ...

A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

“Patients with stage III or IV kidney cancer are at high risk of recurrence ... which has many more mutations and therefore many possible neoantigens. But kidney cancer is a disease with fewer ...

The advent of vaccinations came when a scientist, by the name of Edward Jenner, discovered that an individual exposed to a ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

"Patients with stage III or IV kidney cancer are at high risk ... and therefore many possible neoantigens. But kidney cancer is a disease with fewer mutations, and therefore fewer targets to ...